Home
>
National Drug Code (NDC)
>
Staxyn
Staxyn - 0173-0822-14 - (vardenafil hydrochloride)
Drug Information of Staxyn
| Product NDC: | 0173-0822 |
| Proprietary Name: | Staxyn |
| Non Proprietary Name: | vardenafil hydrochloride |
| Active Ingredient(s): | 11.85 mg/1 & nbsp; vardenafil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Staxyn
| Product NDC: | 0173-0822 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200179 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110421 |
Package Information of Staxyn
| Package NDC: | 0173-0822-14 |
| Package Description: | 10 BLISTER PACK in 1 BOX (0173-0822-14) > 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of Staxyn
| NDC Code | 0173-0822-14 |
| Proprietary Name | Staxyn |
| Package Description | 10 BLISTER PACK in 1 BOX (0173-0822-14) > 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 0173-0822 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | vardenafil hydrochloride |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20110421 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | VARDENAFIL HYDROCHLORIDE TRIHYDRATE |
| Strength Number | 11.85 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
